Patents by Inventor Bastian Zimmer

Bastian Zimmer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11959104
    Abstract: The presently disclosed subject matter provides for in vitro methods of inducing differentiation of human stem cells into neural crest, cranial placode or non-neuro ectoderm precursors, and cells generated by such methods. The presently disclosed subject matter also provides for uses of such cells for treating neurodegenerative and pituitary disorders.
    Type: Grant
    Filed: April 4, 2022
    Date of Patent: April 16, 2024
    Assignee: MEMORIAL SLOAN-KETTERING CANCER CENTER
    Inventors: Lorenz Studer, Bastian Zimmer, Jason Tchieu
  • Publication number: 20240067924
    Abstract: Cranial placodes are embryonic structures essential for sensory and endocrine organ development. The efficient derivation of cranial placodes from human pluripotent stem cells is disclosed where the timed removal of the BMP inhibitor Noggin, a component of the dual-SMAD inhibition strategy of neural induction, triggers placode induction at the expense of CNS fates. Further fate specification at the pre-placode stage enables the selective generation of placode-derived trigeminal ganglia capable of in vivo engraftment, mature lens fibers and anterior pituitary hormone-producing cells that upon transplantation produce hormones including, but not limited to, human growth hormone and adrenocortiocotropic hormone in vivo. Alternatively, anterior pituitary hormone-producing cells are generated in cell culture systems in vitro.
    Type: Application
    Filed: December 21, 2022
    Publication date: February 29, 2024
    Applicant: MEMORIAL SLOAN-KETTERING CANCER CENTER
    Inventors: Stuart Chambers, Lorenz Studer, Zehra Dincer, Bastian Zimmer
  • Patent number: 11591567
    Abstract: Cranial placodes are embryonic structures essential for sensory and endocrine organ development. The efficient derivation of cranial placodes from human pluripotent stem cells is disclosed where the timed removal of the BMP inhibitor Noggin, a component of the dual-SMAD inhibition strategy of neural induction, triggers placode induction at the expense of CNS fates. Further fate specification at the pre-placode stage enables the selective generation of placode-derived trigeminal ganglia capable of in vivo engraftment, mature lens fibers and anterior pituitary hormone-producing cells that upon transplantation produce hormones including, but not limited to, human growth hormone and adrenocortiocotropic hormone in vivo. Alternatively, anterior pituitary hormone-producing cells are generated in cell culture systems in vitro.
    Type: Grant
    Filed: April 2, 2019
    Date of Patent: February 28, 2023
    Assignee: MEMORIAL SLOAN-KETTERING CANCER CENTER
    Inventors: Stuart Chambers, Lorenz Studer, Zehra Dincer, Bastian Zimmer
  • Publication number: 20220228123
    Abstract: The presently disclosed subject matter provides for in vitro methods of inducing differentiation of human stem cells into neural crest, cranial placode or non-neuro ectoderm precursors, and cells generated by such methods. The presently disclosed subject matter also provides for uses of such cells for treating neurodegenerative and pituitary disorders.
    Type: Application
    Filed: April 4, 2022
    Publication date: July 21, 2022
    Applicant: MEMORIAL SLOAN-KETTERING CANCER CENTER
    Inventors: Lorenz STUDER, Bastian ZIMMER, Jason TCHIEU
  • Patent number: 11326148
    Abstract: The presently disclosed subject matter provides for in vitro methods of inducing differentiation of human stem cells into neural crest, cranial placode or non-neuro ectoderm precursors, and cells generated by such methods. The presently disclosed subject matter also provides for uses of such cells for treating neurodegenerative and pituitary disorders.
    Type: Grant
    Filed: August 3, 2018
    Date of Patent: May 10, 2022
    Assignee: MEMORIAL SLOAN-KETTERING CANCER CENTER
    Inventors: Lorenz Studer, Bastian Zimmer, Jason Tchieu
  • Patent number: 10747413
    Abstract: Embodiments relate to apparatuses, methods and computer programs for controlling a machine. The apparatus is suitable for a mobile communication device for providing a sensor input signal to a machine control entity to control a machine. The apparatus comprises one or more sensor modules for providing first user input sensor data and second user input sensor data. The apparatus further comprises a control module configured to determine the sensor input signal based on the first user input sensor data and the second user input sensor data. The control module is further configured to provide the sensor input signal for sensor data processing to the machine control entity to control the machine via an interface.
    Type: Grant
    Filed: November 2, 2016
    Date of Patent: August 18, 2020
    Assignee: Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.
    Inventors: Daniel Schneider, Thomas Kuhn, Rasmus Adler, Viet Yen Nguyen, Patrik Feth, Emilia Cioroaica, Bastian Zimmer, Martin Kremmer, Thomas Floerchinger, Benjamin Neermann, Norbert Fritz, Stefan Volz
  • Publication number: 20200199530
    Abstract: The presently disclosed subject matter provides in vitro methods of inducing differentiation of stem cells to neural crest, cranial placode or non-neuro ectoderm precursors, and cells generated by such methods. The presently disclosed subject matter also provides uses of such cells for treating neurodegenerative and pituitary disorders.
    Type: Application
    Filed: March 5, 2020
    Publication date: June 25, 2020
    Applicant: MEMORIAL SLOAN-KETTERING CANCER CENTER
    Inventors: Lorenz Studer, Bastian Zimmer, Jason Tchieu
  • Publication number: 20190225939
    Abstract: Cranial placodes are embryonic structures essential for sensory and endocrine organ development. The efficient derivation of cranial placodes from human pluripotent stem cells is disclosed where the timed removal of the BMP inhibitor Noggin, a component of the dual-SMAD inhibition strategy of neural induction, triggers placode induction at the expense of CNS fates. Further fate specification at the pre-placode stage enables the selective generation of placode-derived trigeminal ganglia capable of in vivo engraftment, mature lens fibers and anterior pituitary hormone-producing cells that upon transplantation produce hormones including, but not limited to, human growth hormone and adrenocortiocotropic hormone in vivo. Alternatively, anterior pituitary hormone-producing cells are generated in cell culture systems in vitro.
    Type: Application
    Filed: April 2, 2019
    Publication date: July 25, 2019
    Applicant: MEMORIAL SLOAN-KETTERING CANCER CENTER
    Inventors: Stuart Chambers, Lorenz Studer, Zehra Dincer, Bastian Zimmer
  • Patent number: 10273452
    Abstract: Cranial placodes are embryonic structures essential for sensory and endocrine organ development. The efficient derivation of cranial placodes from human pluripotent stem cells is disclosed where the timed removal of the BMP inhibitor Noggin, a component of the dual-SMAD inhibition strategy of neural induction, triggers placode induction at the expense of CNS fates. Further fate specification at the pre-placode stage enables the selective generation of placode-derived trigeminal ganglia capable of in vivo engraftment, mature lens fibers and anterior pituitary hormone-producing cells that upon transplantation produce hormones including, but not limited to, human growth hormone and adrenocortiocotropic hormone in vivo. Alternatively, anterior pituitary hormone-producing cells are generated in cell culture systems in vitro.
    Type: Grant
    Filed: May 19, 2016
    Date of Patent: April 30, 2019
    Assignee: MEMORIAL SLOAN-KETTERING CANCER CENTER
    Inventors: Stuart Chambers, Lorenz Studer, Zehra Dincer, Bastian Zimmer
  • Publication number: 20190071643
    Abstract: The presently disclosed subject matter provides for in vitro methods of inducing differentiation of human stem cells into neural crest, cranial placode or non-neuro ectoderm precursors, and cells generated by such methods. The presently disclosed subject matter also provides for uses of such cells for treating neurodegenerative and pituitary disorders.
    Type: Application
    Filed: August 3, 2018
    Publication date: March 7, 2019
    Applicant: MEMORIAL SLOAN-KETTERING CANCER CENTER
    Inventors: Lorenz STUDER, Bastian ZIMMER, Jason TCHIEU
  • Publication number: 20170228145
    Abstract: Embodiments relate to apparatuses, methods and computer programs for controlling a machine. The apparatus is suitable for a mobile communication device for providing a sensor input signal to a machine control entity to control a machine. The apparatus comprises one or more sensor modules for providing first user input sensor data and second user input sensor data. The apparatus further comprises a control module configured to determine the sensor input signal based on the first user input sensor data and the second user input sensor data. The control module is further configured to provide the sensor input signal for sensor data processing to the machine control entity to control the machine via an interface.
    Type: Application
    Filed: November 2, 2016
    Publication date: August 10, 2017
    Inventors: Daniel Schneider, Thomas Kuhn, Rasmus Adler, Viet Yen Nguyen, Patrik Feth, Emilia Cioroaica, Bastian Zimmer, Martin Kremmer, Thomas Floerchinger, Benjamin Neermann, Norbert Fritz, Stefan Volz
  • Publication number: 20160326491
    Abstract: Cranial placodes are embryonic structures essential for sensory and endocrine organ development. The efficient derivation of cranial placodes from human pluripotent stem cells is disclosed where the timed removal of the BMP inhibitor Noggin, a component of the dual-SMAD inhibition strategy of neural induction, triggers placode induction at the expense of CNS fates. Further fate specification at the pre-placode stage enables the selective generation of placode-derived trigeminal ganglia capable of in vivo engraftment, mature lens fibers and anterior pituitary hormone-producing cells that upon transplantation produce hormones including, but not limited to, human growth hormone and adrenocortiocotropic hormone in vivo. Alternatively, anterior pituitary hormone-producing cells are generated in cell culture systems in vitro.
    Type: Application
    Filed: May 19, 2016
    Publication date: November 10, 2016
    Inventors: Stuart Chambers, Lorenz Studer, Zehra Dincer, Bastian Zimmer